奥扎格雷钠联合依达拉奉治疗脑血栓的临床探析

Clinical Study on Ozagrel Combined With Edaravone Medication in Treatment of Cerebral Thrombosis

目的：探析奥扎格雷钠联合依达拉奉在治疗脑血栓方面的临床效果。方法搜集本院心脑血管科2014年1月～2015年1月收治的46例脑血栓患者，随机分为实验组和对照组，对照组给予单纯奥扎格雷钠药物，实验组给予奥扎格雷钠联合依达拉奉药物，对比疗效。结果与对照组81.8%（18/22）比较，实验组患者的治疗好转率95.8%（23/24）更高，神经功能缺损NIHSS和日常生活能力BI优于对照组，差异较大， P＜0.05。结论奥扎格雷钠联合依达拉奉治疗脑血栓的疗效显著，患者的神经功能和生活自理能力显著提高，治疗好转率高。

Objective To Clinical effect of Ozagrel combined with Edaravone medication in treatment of cerebral thrombosis is to be studied. MethodsChoose 46 patients of cerebral thrombosis that are treated in hospital from January 2014 to January 2015 and separate them into study group and control group at random; patients in control group are given Ozagrel medication treatment only, while patients in study group are given Ozagrel combined with Edaravone medication treatment and then compare treatment effects between two groups.Results Patients’ treatment improvement rate in study group is up to 95.8% （23/24）, which is much higher than 81.8% （18/22） in control group; besides, patients’ neurology function damage （NIHSS） and their self-care ability of daily life （BI） in study group are much more favorable than counterparts in control group; there is a treatment differential between two groups and such a differential has statistic value （P〈0.05）.Conclusion Ozagrel combined with Edaravone medication is of efifcacy in treatment of cerebral thrombosis; it is conducive to improving patients’ neurology function damage and their self-care ability of daily life signiifcantly with high treatment improvement rate; thus, such a medication treatment is of great application value.